The FDA Vaccines and Related Biological Products Advisory Committee holds a meeting at 9 a.m. ET on March 12 to discuss and make recommendations on the strain composition of influenza virus vaccines for use in the United States during the 2026–2027 influenza season.
FDA Vaccines and Related Biological Products Advisory Committee Holds Meeting
The FDA Vaccines and Related Biological Products Advisory Committee holds a meeting to discuss and make recommendations on the strain composition of influenza virus vaccines for use in the United States during the 2026–2027 influenza season.
Live Chat
